Interestingly, it was observed that inhibition of STAT3 activity by Penta-1,2,3,4,6-O-galloylbeta- D-glucose is P53 dependent in prostate cancer cells in vitro and defeats prostate xenograft tumor growth in vivo [128]. Here, STAT3 is linked to neoplasm.